Acrisure Announces Proposed Notes Offering
GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Acrisure, LLC (the “Company”) and Acrisure Finance, Inc. (together with the Company, the “Issuers”) announced... Read more.
Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome
– Plozasiran achieved statistically significant median reductions in triglycerides up to 80% and mean reductions in APOC3 up to 94% at month 10 – Plozasiran... Read more.
Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program
NGN-401 is one of only three CBER programs chosen by FDA NGN-401 was selected based on potential for clinical benefits and clinical development program readiness... Read more.
Newegg Announces New SaaS Multichannel Marketplace Management Solution — SellingPilot
Modern marketplace platform leverages company’s e-commerce expertise and AI development CITY OF INDUSTRY, Calif.–(BUSINESS WIRE)–$NEGG #marketplace—Newegg... Read more.
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
Surveillance Monitoring with Both AlloSure Kidney and the AlloView AI-Enabled Risk Prediction Model Improves the Detection of All Types of Allograft Rejection AlloSure... Read more.
RadiusXR Achieves ISO 13485 and MDSAP Certifications, Announces Expansion into Canadian Market
PLEASANTON, Calif.–(BUSINESS WIRE)–#Ophthalmology—RadiusXR, a leading innovator in digital health technology, is proud to announce that it has... Read more.
SAIC Announces First Quarter of Fiscal Year 2025 Results
Revenues of $1.85 billion; 0.4% organic growth; organic growth reflects impacts of divestitures Net income of $77 million; Adjusted EBITDA(1) of $166 million or... Read more.
IDRx Reports Updated Preliminary Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial Supporting Best-in-Class Potential for IDRX-42 in Patients with GIST
Encouraging signs of activity were observed, including a 23% objective response rate (ORR) across all patients (median four prior lines of therapy) and a 43% ORR... Read more.
ProPetro Acquires Aqua Prop, an Innovative Wet Sand Solutions Provider
MIDLAND, Texas–(BUSINESS WIRE)–ProPetro Holding Corp. (“ProPetro” or the “Company”) (NYSE: PUMP) today announced the acquisition of Aqua Prop... Read more.
Rockwell Automation to Advance Intelligent Automation, Mobile Robotics in Manufacturing Logistics in Collaboration with NVIDIA
OTTO Motors by Rockwell Automation will create next-generation autonomous mobile robots enhanced with NVIDIA technologies MILWAUKEE–(BUSINESS WIRE)–Rockwell... Read more.